Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals
Ho-Shan Niu,1 Po-Ming Ku,2,3 Chiang-Shan Niu,1 Juei-Tang Cheng,3,4 Kung-Shing Lee5–71Department of Nursing, Tzu Chi College of Technology, Hualien City, 2Department of Cardiology, 3Department of Medical Research, Chi-Mei Medical Center, Yong Kang, Tainan City, 4Institute of Medical Science...
Saved in:
Main Authors: | Niu HS (Author), Ku PM (Author), Niu CS (Author), Cheng JT (Author), Lee KS (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PPAR-γ Agonist GW1929 Targeted to Macrophages with Dendrimer-Graphene Nanostars Reduces Liver Fibrosis and Inflammation
by: Alazne Moreno-Lanceta, et al.
Published: (2023) -
Eucommia bark (Du-Zhong) improves diabetic nephropathy without altering blood glucose in type 1-like diabetic rats
by: Niu HS, et al.
Published: (2016) -
PPARβ/δ Agonist GW501516 Inhibits Tumorigenicity of Undifferentiated Nasopharyngeal Carcinoma in C666-1 Cells by Promoting Apoptosis
by: Yangyang Ji, et al.
Published: (2018) -
Erythropoietin ameliorates hyperglycemia in type 1-like diabetic rats
by: Niu HS, et al.
Published: (2016) -
Limited Applicability of GW9662 to Elucidate PPARγ-Mediated Fatty Acid Effects in Primary Human T-Helper Cells
by: Anke Jaudszus, et al.
Published: (2014)